✦ LIBER ✦

Perioperative Treatment with Infliximab in Patients with Crohn’s Disease and Ulcerative Colitis is Not Associated with an Increased Rate of Postoperative Complications

✍ Scribed by Hiroko Kunitake; Richard Hodin; Paul C. Shellito; Bruce E. Sands; Joshua Korzenik; Liliana Bordeianou

Book ID: 107410405
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 161 KB
Volume: 12
Category: Article
ISSN: 1091-255X
DOI: 10.1007/s11605-008-0630-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab in Ulcerative Colitis is Asso

Infliximab in Ulcerative Colitis is Associated with an Increased Risk of Postoperative Complications After Restorative Proctocolectomy

✍ I. J. Mor; J. D. Vogel; A. da Luz Moreira; B. Shen; J. Hammel; F. H. Remzi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 174 KB

Crohn's disease-associated genetic marke

Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications

✍ Katherine Facklis; Scott E. Plevy; Eric A. Vasiliauskas; Lori Kam; Kent Taylor; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 632 KB

Preoperative infliximab treatment in pat

Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery

✍ Liliana Bordeianou; Hiroko Kunitake; Paul Shellito; Richard Hodin 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 99 KB

Preoperative Infliximab is not Associate

Preoperative Infliximab is not Associated with an Increased Risk of Short-Term Postoperative Complications After Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis

✍ Melanie L. Gainsbury; Daniel I. Chu; Lauren A. Howard; Jennifer A. Coukos; Franc 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 144 KB

Safety and tolerability of concurrent na

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

Safety and tolerability of concurrent na

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 2 views

## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ